Invitae Corp

Ownership Transactions Reported by 20 Insiders

Symbol
NVTAQ on OTC
Industry
Services-Medical Laboratories
Location
1400 16 Th Street, San Francisco, CA

There are no Buy or Sell transactions made by insiders since 9/13/2023

Invitae Corp executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Kenneth D. Knight Chief Executive Officer, Director $1.08M May 16, 2023
Thomas Brida General Counsel, Chief Compliance Officer and Secretary $594K Dec 20, 2023
Ana J. Schrank Chief Financial Officer $551K Oct 2, 2023
David Sholehvar Chief Operating Officer $551K Nov 13, 2023
Robert M. Guigley Chief Commercial Officer $551K Sep 23, 2023
Sean E. George Director $475K Dec 16, 2022
Yafei Wen Chief Financial Officer $454K May 16, 2023
Robert L. Nussbaum Chief Medical Officer $358K Dec 20, 2023
Robert F. Werner Chief Accounting Officer $230K May 16, 2023
Shelly D. Guyer Chief Financial Officer $157K Jun 14, 2021
Randal W. Scott Director $143K Apr 27, 2023
Katherine Stueland Chief Commercial Officer $139K Jun 14, 2021
William H. Osborne Director $103K Apr 27, 2023
Geoffrey Crouse Director $84.4K Apr 27, 2023
Eric Aguiar Director $81.2K Apr 27, 2023
Chitra Nayak Director $71.9K Apr 27, 2023
Christine Marie Gorjanc Director $71.9K Apr 27, 2023
Kimber D. Lockhart Director $71.9K Apr 27, 2023
Jeff Parsons Interim Chief Accounting Officer Exhibit List: Exhibit 24 - Power of Attorney Jul 1, 2023
Robert Dickey Interim Chief Financial Officer Exhibit List: Exhibit 24 - Power of Attorney Aug 14, 2023

Recent Insider Transactions by Companies or Individuals for Invitae Corp

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.